The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine
The Oncologist (2009) - Comment
pubmed: 19346299  doi: 10.1634/theoncologist.2008-0230  issn: 1549-490x  issn: 1083-7159 

Jeffrey S. Ross, Elzbieta A. Slodkowska, W. Fraser Symmans, Lajos Pusztai, Peter M. Ravdin, Gabriel N. Hortobagyi